The Real DAPSI: A Real-World Retrospective Study on Assessing the Efficacy and Safety of a Fixed-Dose Combination of Dapagliflozin and Sitagliptin in the Indian Population-Reference-Cited by-同舟云学术

The Real DAPSI: A Real-World Retrospective Study on Assessing the Efficacy and Safety of a Fixed-Dose Combination of Dapagliflozin and Sitagliptin in the Indian Population

Published:2023-10-09 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Bhattacharjee Rana,Rai Madhukar,Joshi Priyanka,Prasad Ashish,Birla Ashish

Publisher

Springer Science and Business Media LLC

Subject

Aerospace Engineering

Reference20 articles.

1. Epidemiology of type 2 diabetes in India;Pradeepa R;Indian J Ophthalmol,2021

2. Epidemiology of diabetes and diabetes-related complications;Deshpande AD;Phys Ther,2008

3. Managing the multifaceted nature of type 2 diabetes using once-weekly injectable GLP-1 receptor agonist therapy;Bzowyckyj A;J Clin Pharm Ther,2020

4. Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA;Mauricio D;Diabetes Obes Metab,2017

5. Dapagliflozin: cardiovascular safety and benefits in type 2 diabetes mellitus;Saleem F;Cureus,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Lipid Profile of Diabetic Patients Using Statins: A Retrospective Cohort Study in the Diabetic Center of King Salman Bin Abdulaziz Hospital, Saudi Arabia;Cureus;2024-07-27

2. Retrospective Observational Study on Assessing Sitagliptin and Dapagliflozin as a Fixed-Dose Combination in the Indian Population With Type 2 Diabetes Mellitus: The SIDAXA Study;Cureus;2024-05-21